Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Solid Tumor Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT05904496
What this trial is testing

BGB-30813 Alone or in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors
BeiGene 44
Early research (Phase 1)Looking for participantsNCT06374173
What this trial is testing

Evaluate TGI-6 in Subjects With Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Hefei TG ImmunoPharma Co., Ltd. 123
Early research (Phase 1)WithdrawnNCT06681870
What this trial is testing

ASP1893 in Adults With Advanced CLDN6-positive Solid Tumors

Who this might be right for
CLDN6-positive Solid TumorOvarian CancerEndometrial Cancer+3 more
Astellas Pharma Global Development, Inc.
Early research (Phase 1)Active Not RecruitingNCT05143970
What this trial is testing

First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors

Who this might be right for
Metastatic CancerMetastatic Breast CancerMetastatic Pancreatic Cancer+6 more
Institut Paoli-Calmettes 27
Early research (Phase 1)UnknownNCT03774979
What this trial is testing

SHR-1701 in Subjects With Metastatic or Locally Advanced Solid Tumors

Who this might be right for
Solid Tumor
Jiangsu HengRui Medicine Co., Ltd. 193
Testing effectiveness (Phase 2)Ended earlyNCT03138083
What this trial is testing

OMO-1 in Solid Malignancies

Who this might be right for
Neoplasms
Octimet Oncology N.V. 40
Not applicableEnded earlyNCT01190241
What this trial is testing

Targeted Therapy Selection Based on Tumor Tissue Kinase Activity Profiles for Patients With Advanced Solid Malignancies, an Exploratory Study

Who this might be right for
Advanced Solid TumorsInoperableMetastasis
Amsterdam UMC, location VUmc 45
Early research (Phase 1)Study completedNCT03525925
What this trial is testing

Ibrutinib and Nivolumab in Treating Participants With Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid Neoplasm
Ohio State University Comprehensive Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT02304458
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas

Who this might be right for
Metastatic MelanomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 140
Early research (Phase 1)Ended earlyNCT05490043
What this trial is testing

A Trial of ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorMature B-cell Non-Hodgkin Lymphoma
Antengene (Hangzhou) Biologics Co., Ltd. 33
Early research (Phase 1)Looking for participantsNCT06880549
What this trial is testing

MRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors

Who this might be right for
Advanced Solid Tumors
ModernaTX, Inc. 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06435455
What this trial is testing

GH21 Combined With D-1553 in KRAS G12C Mutant Advanced Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors Harboring KRAS G12C Mutation
Suzhou Genhouse Bio Co., Ltd. 126
Very early researchNot Yet RecruitingNCT07182435
What this trial is testing

Exploratory Clinical Study of Personalized mRNA Tumor Vaccine RH125 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor Malignancies
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center 36
Early research (Phase 1)Study completedNCT00676949
What this trial is testing

Safety Study of Cancer Specific Epitope Peptides Cocktail for Cervical, GI, and Lung Tumors

Who this might be right for
Metastatic Tumors
Kyushu University 18
Early research (Phase 1)Study completedNCT02884726
What this trial is testing

Phase 1 Study of Mesothelin-ADC

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 8
Early research (Phase 1)Study completedNCT01922752
What this trial is testing

To Determine the Maximum Tolerated Dose of Oral CEP-37440 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Teva Branded Pharmaceutical Products R&D, Inc. 32
Testing effectiveness (Phase 2)Study completedNCT01771458
What this trial is testing

Phase II Trial Comparing Therapy Based on Tumor Molecular Profiling Versus Conventional Therapy in Patients With Refractory Cancer

Who this might be right for
Reccurent/Metastatic Solid Tumor Disease
Institut Curie 742
Not applicableStudy completedNCT00890435
What this trial is testing

Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaUnspecified Adult Solid Tumor, Protocol Specific+1 more
Children's Oncology Group 53
Large-scale testing (Phase 3)Study completedNCT04799249
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)

Who this might be right for
TNBC - Triple-Negative Breast CancerBreast Cancer
G1 Therapeutics, Inc. 194
Early research (Phase 1)Study completedNCT00379132
What this trial is testing

131-I-TM-601 Study in Adults With Solid Tumors

Who this might be right for
Breast CancerNon-Small Cell Lung CancerMelanoma+5 more
TransMolecular 60
Next Page